PS

Pramod Suresh Kashid

Active Director Additional Director DIN 11498139
DIN 11498139 First appointment Jan 2026
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value •••• Premium profile

About Pramod Suresh Kashid

Data last updated:

Pramod Suresh Kashid is an Additional Director at Expecto Health Science Private Limited (since 2026). Expecto Health Science Private Limited reported revenue of ₹1.37 Cr (FY 2025).

DIN 11498139
Primary Designation Additional Director
First Appointment 22 Jan 2026
Largest company Expecto Health Science Private Limited · ₹1.37 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director22 Jan 2026₹1.37 Cr (FY 2025)Active

Board colleagues of Pramod Suresh Kashid

Directorship timeline

Open interactive timeline →
Expecto Health Science Private Limited
Premium access

Shareholding and investment profile for Pramod Suresh Kashid

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pramod Suresh Kashid

Pramod Suresh Kashid currently holds 1 directorship: Expecto Health Science Private Limited (Additional Director, since 22 Jan 2026, revenue ₹1.37 Cr (FY 2025)).

Pramod Suresh Kashid was first appointed on 22 Jan 2026 as Additional Director at Expecto Health Science Private Limited.

The current boards of Pramod Suresh Kashid's companies include Priyanka Amol Kashid (Expecto Health Science Private Limited), Sachin Subhashrao Patil (Expecto Health Science Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available